Artificial intelligence-based donor oocyte quality assessment moderately improves the prediction of blastocyst development: a first step towards higher personalization in the management of egg donation treatments.

Journal: Human reproduction (Oxford, England)

Published Date: Aug 4, 2025

STUDY QUESTION: Can an artificial intelligence (AI)-based oocyte scoring system reliably predict the developmental competence of fresh donor oocytes?

Danilo Cimadomo

GeneraLife IVF, Clinica Valle Giulia, Rome, Italy. Electronic address: cimadomo@generaroma.it.
Vicente Badajoz

IVIRMA Global Research Alliance, GINEFIV, Madrid, Spain.
Maria Hebles

IVIRMA Global Research Alliance, GINEMED, Sevilla, Spain.
Laura Mifsud

IVIRMA Global Research Alliance, Ginefiv, Barcelona, Spain.
Cristina Urda

IVIRMA Global Research Alliance, Ginefiv, Madrid, Spain.
Teresa Sánchez

IVIRMA Global Research Alliance, Ginefiv, Madrid, Spain.
Aitana Sánchez

IVIRMA Global Research Alliance, Ginefiv, Madrid, Spain.
Cristina Ortega

IVIRMA Global Research Alliance, Ginemed, Sevilla, Spain.
Javier Ávila

IVIRMA Global Research Alliance, Ginemed, Sevilla, Spain.
Clara Mariné

IVIRMA Global Research Alliance, Ginefiv, Barcelona, Spain.
Natalie Mercuri

Future Fertility, Toronto, Ontario, Canada.
Jullin Fjeldstad

Future Fertility, Toronto, Ontario, Canada. Electronic address: jullinf@futurefertility.com.
Alex Krivoi

Future Fertility, Toronto, Ontario, Canada.
Dan Nayot

Future Fertility, Toronto, Ontario, Canada.
Laura Rienzi

GeneraLife IVF, Clinica Valle Giulia, Rome, Italy.

No keywords available for this article.

View on PubMed Access via DOI PubMed (40759152)